BG Medicine, Inc. (BGMD)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Dec 3, 2025
BG Medicine Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | 2006 - 2010 |
|---|---|---|---|---|---|---|
Period Ending | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2006 - 2010 |
| Net Income | -5.3 | -8.06 | -15.85 | -23.77 | -17.58 | Upgrade
|
| Depreciation & Amortization | 0.09 | 0.13 | 0.17 | 0.27 | 0.42 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.06 | - | -0.05 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.11 | - | - | Upgrade
|
| Stock-Based Compensation | 0.83 | 0.67 | 1.16 | 2.36 | 1.87 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.15 | - | - | - | - | Upgrade
|
| Other Operating Activities | 0.53 | 0.22 | 0.55 | 0.19 | 0.13 | Upgrade
|
| Change in Accounts Receivable | -0.16 | 0.15 | 0.08 | -0.28 | 0.67 | Upgrade
|
| Change in Inventory | 0.26 | 0.06 | -0.01 | -0.24 | -0.21 | Upgrade
|
| Change in Accounts Payable | -0.64 | -1.4 | -1.65 | 0.8 | 0.54 | Upgrade
|
| Change in Unearned Revenue | 0.47 | -0.04 | -0.39 | -0.96 | -0.15 | Upgrade
|
| Change in Other Net Operating Assets | 0.05 | 0.11 | 0.6 | 0.29 | -0.65 | Upgrade
|
| Operating Cash Flow | -3.67 | -8.17 | -15.29 | -21.33 | -14.97 | Upgrade
|
| Capital Expenditures | - | - | -0.13 | -0.09 | -0.09 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | - | 0.1 | - | - | Upgrade
|
| Investing Cash Flow | 0.01 | - | -0.03 | -0.09 | -0.09 | Upgrade
|
| Short-Term Debt Issued | 0.5 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | - | - | - | 10 | - | Upgrade
|
| Total Debt Issued | 0.5 | - | - | 10 | - | Upgrade
|
| Long-Term Debt Repaid | -2.98 | -4.48 | -2.53 | - | -0.1 | Upgrade
|
| Total Debt Repaid | -2.98 | -4.48 | -2.53 | - | -0.1 | Upgrade
|
| Net Debt Issued (Repaid) | -2.48 | -4.48 | -2.53 | 10 | -0.1 | Upgrade
|
| Issuance of Common Stock | 2.5 | 9.26 | 13.11 | 0.59 | 37.9 | Upgrade
|
| Other Financing Activities | -0.96 | -0.24 | -0.29 | -0.26 | -1.3 | Upgrade
|
| Financing Cash Flow | 1.06 | 4.54 | 10.29 | 10.33 | 36.51 | Upgrade
|
| Net Cash Flow | -2.6 | -3.63 | -5.04 | -11.09 | 21.45 | Upgrade
|
| Free Cash Flow | -3.67 | -8.17 | -15.42 | -21.42 | -15.06 | Upgrade
|
| Free Cash Flow Margin | -234.16% | -293.04% | -378.59% | -760.85% | -921.60% | Upgrade
|
| Free Cash Flow Per Share | -0.38 | -1.00 | -2.27 | -4.24 | -3.42 | Upgrade
|
| Cash Interest Paid | 0.12 | 0.51 | 0.86 | 0.76 | 0 | Upgrade
|
| Levered Free Cash Flow | -2.11 | -5.02 | -9.89 | -12.81 | -9.56 | Upgrade
|
| Unlevered Free Cash Flow | -2.01 | -4.57 | -9.16 | -12.14 | -9.5 | Upgrade
|
| Change in Working Capital | -0.02 | -1.13 | -1.37 | -0.39 | 0.2 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.